VEA
WST icon

Virtus ETF Advisers’s West Pharmaceutical WST Stock Holding History

Virtus ETF Advisers’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,225
Closed -$733K – 488
2024
Q2 		$733K Buy
2,225
+68
+3% +$24K 0.36% 162
2024
Q1 		$854K Buy
2,157
+579
+37% +$214K 0.45% 62
2023
Q4 		$556K Sell
1,578
-402
-20% -$142K 0.35% 126
2023
Q3 		$743K Buy
+1,980
New +$766K 0.45% 56
2022
Q3 		– Sell
-2,061
Closed -$623K – 472
2022
Q2 		$623K Buy
+2,061
New +$671K 0.23% 178

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtus ETF Advisers's WST Position: Q3 2024 in Review

Virtus ETF Advisers sold out of West Pharmaceutical (WST) in Q3 2024, closing a stake of 2,225 shares — an estimated $733K sold.

Virtus ETF Advisers first reported a position in WST in Q2 2022 and held it in 5 quarters. The position peaked at $854K in Q1 2024. 729 funds tracked by Wall St. Rank hold WST as of Q3 2024.

  • Virtus ETF Advisers reported no remaining West Pharmaceutical position as of Q3 2024 after selling out during the quarter.
  • Virtus ETF Advisers sold 2,225 West Pharmaceutical shares in Q3 2024, an estimated $733K.
  • Virtus ETF Advisers first reported a position in West Pharmaceutical in Q2 2022 and held it in 5 quarters.
  • Virtus ETF Advisers's West Pharmaceutical position peaked at $854K in Q1 2024.
  • 729 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on Virtus ETF Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.